Shuya Otsuki, Ryusuke Hori, S. Shinohara, Tsuyoshi Kojima, H. Tamaki, Ryo Asato, Morimasa Kitamura, K. Ichimaru, Yoshiharu Kitani, Yohei Kumabe, Keigo Honda, T. Tsujimura, Hiroyuki Harada, Koji Ushiro, Koichi Omori
{"title":"接受 nivolumab 治疗的复发性或转移性头颈部鳞状细胞癌患者的两年长期疗效和预后因素的真实情况","authors":"Shuya Otsuki, Ryusuke Hori, S. Shinohara, Tsuyoshi Kojima, H. Tamaki, Ryo Asato, Morimasa Kitamura, K. Ichimaru, Yoshiharu Kitani, Yohei Kumabe, Keigo Honda, T. Tsujimura, Hiroyuki Harada, Koji Ushiro, Koichi Omori","doi":"10.3950/jibiinkotokeibu.127.3_189","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":511744,"journal":{"name":"Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)","volume":" 39","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck\",\"authors\":\"Shuya Otsuki, Ryusuke Hori, S. Shinohara, Tsuyoshi Kojima, H. Tamaki, Ryo Asato, Morimasa Kitamura, K. Ichimaru, Yoshiharu Kitani, Yohei Kumabe, Keigo Honda, T. Tsujimura, Hiroyuki Harada, Koji Ushiro, Koichi Omori\",\"doi\":\"10.3950/jibiinkotokeibu.127.3_189\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":511744,\"journal\":{\"name\":\"Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)\",\"volume\":\" 39\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3950/jibiinkotokeibu.127.3_189\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3950/jibiinkotokeibu.127.3_189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neck